Radiation therapy for prevention of heterotopic ossification about the elbow

Strahlentherapie und Onkologie

Volumn 185, Issue 8, 2009, Pages 506-511

  Heyd, Reinhard ^b   Buhleier, Thomas ^c   Zamboglou, Nikolaos ^a  

^a Klinikum Offenbach   (Germany)

^b Klinikum Offenbach GmbH   (Germany)

^c NONE

Author keywords

Benign disease; Elbow; Heterotopic ossification; Mayo Elbow Performance Score; Radiation therapy

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DISEASE CONTROL; DISEASE COURSE; ELBOW; EXCISION; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; FUNCTIONAL DISEASE; HETEROTOPIC OSSIFICATION; HUMAN; JOINT FUNCTION; MALE; MAYO ELBOW PERFORMANCE SCORE; PERIOPERATIVE PERIOD; POSTOPERATIVE CARE; PREOPERATIVE RADIOTHERAPY; PROPHYLAXIS; RADIATION DOSE; RADIOGRAPHY; RADIOTHERAPY; RECURRENT DISEASE; RISK FACTOR; SCORING SYSTEM; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ARTHROPLASTY, REPLACEMENT; DEVICE REMOVAL; DISLOCATIONS; ELBOW JOINT; FEMALE; FOLLOW-UP STUDIES; FRACTURE FIXATION, INTERNAL; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; OSSIFICATION, HETEROTOPIC; POSTOPERATIVE COMPLICATIONS; RADIOTHERAPY, ADJUVANT; RANGE OF MOTION, ARTICULAR; RECURRENCE; YOUNG ADULT;

EID: 68349130386     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-009-1968-x     Document Type: Article

References (44)

1. F.J. Attenello D. Mukherjee G. Datoo 2008 Use of Gliadel (BCNU) wafer in the surgical treatment of malignant glioma: a 10-year institutional experience Ann Surg Oncol 15 2887 93
2. K.V. Ballman J.C. Buckner P.D. Brown 2007 The relationship between six-month progression-free survival and 12-month overall survival end points for phase II trials in patients with glioblastoma multiforme Neurooncology 9 29 38
3. 90Y-biotin radioimmunotherapy and temozolomide Q J Nucl Med Mol Imaging 48 220 8
4. M. Bernstein N. Laperriere J. Glen 1994 Brachytherapy for recurrent astrocytoma Int J Radiat Oncol Biol Phys 30 1213 7
5. A. Boiardi A. Silvani M. Eoli 2008 Treatment of recurrent glioblastoma: can local delivery of mitoxantrone improve survival? J Neurooncol 88 105 13
6. H. Brem S. Piantadosi P.C. Burger 1995 Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group Lancet 345 1008 12
7. M.C. Chamberlain D. Barba P. Kormanik 1994 Stereotactic radiosurgery for recurrent gliomas Cancer 74 1342 7
8. T.A. Chan J.D. Weingart M. Parisi 2005 Treatment of recurrent glioblastoma multiforme with Gliasite brachytherapy Int J Radiat Oncol Biol Phys 62 1133 9
9. F. Colombo P. Francescon C. Cavedon 2001 Employ of a new device for intra-operative radiotherapy of intracranial tumours Acta Neurochir (Wien) 143 827 31
10. S.E. Combs S. Gutwein D. Schulz-Ertner 2005 Temozolomide combined with irradiation as postoperative treatment of primary glioblastoma multiforme. Phase I/II study Strahlenther Onkol 181 372 7
11. S.E. Combs S. Gutwein C. Thilmann 2005 Reirradiation of recurrent WHO grade III astrocytomas using fractionated stereotactic radiotherapy (FSRT) Strahlenther Onkol 181 768 73
12. S.E. Combs V. Widmer C. Thilmann 2005 Stereotactic radiosurgery (SRS): treatment option for recurrent glioblastoma multiforme (GBM) Cancer 104 2168 73
13. W.J. Curran Jr C.B. Scott J. Horton 1993 Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials J Natl Cancer Inst 85 704 10
14. L.M. DeAngelis 2005 Chemotherapy for brain tumors - a new beginning N Engl J Med 352 1036 8
15. Devlin PM. Brachytherapy applications and techniques. Philadelphia: Lippincott Williams & Wilkins, 2007.
16. A. Ernst-Stecken O. Ganslandt U. Lambrecht 2007 Survival and quality of life after hypofractionated stereotactic radiotherapy for recurrent malignant glioma J Neurooncol 81 287 94
17. A.R. Fathi E. Vassella M. Arnold 2007 Objective response to radiation therapy and long-term survival of patients with WHO grade II astrocytic gliomas with known LOH 1p/19q status Strahlenther Onkol 183 517 22
18. A.J. Gabayan S.B. Green A. Sanan 2006 GliaSite brachytherapy for treatment of recurrent malignant gliomas: a retrospective multi-institutional analysis Neurosurgery 58 701 9
19. G.R. Harsh V.A. Levin P.H. Gutin 1987 Re-operation for recurrent glioblastoma and anaplastic astrocytoma Neurosurgery 21 615 21
20. B.A. Jereczek-Fossa A. Kowalczyk A. D'Onofrio 2008 Three-dimensional conformal or stereotactic reirradiation of recurrent, metastatic or new primary tumors. Analysis of 108 patients Strahlenther Onkol 184 36 40
21. J.A. Kalapurakal S. Goldman W. Stellpflug 2006 Phase I study of intraoperative radiotherapy with photon radiosurgery system in children with recurrent brain tumors: preliminary report of first dose level (10 Gy) Int J Radiat Oncol Biol Phys 65 800 8
22. E.L. Kaplan P. Meier 1958 Non-parametric estimation from incomplete observations J Am Stat Assoc 53 457 81
23. K. Kohshi H. Yamamoto A. Nakahara 2007 Fractionated stereotactic radiotherapy using gamma unit after hyperbaric oxygenation on recurrent high-grade gliomas J Neurooncol 82 297 303
24. D.A. Larson M. Prados K.R. Lamborn 2002 Phase II study of high central dose gamma knife radiosurgery and marimastat in patients with recurrent malignant glioma Int J Radiat Oncol Biol Phys 54 1397 404
25. D.A. Larson J.M. Suplica S.M. Chang 2004 Permanent iodine 125 brachytherapy in patients with progressive or recurrent glioblastoma multiforme Neurooncology 6 119 26
26. S.W. Lee B.A. Fraass L.H. Marsh 1999 Patterns of failure following high-dose 3-D conformal radiotherapy for high-grade astrocytomas: a quantitative dosimetric study Int J Radiat Oncol Biol Phys 43 79 88
27. S.A. Leibel P.H. Gutin W.M. Wara 1989 Survival and quality of life after interstitial implantation of removable high activity iodine-125 sources for the treatment of patients with recurrent malignant gliomas Int J Radiat Oncol Biol Phys 17 1129 39
28. Levin VA, Leibel SA, Gutin PH. Neoplasms of the central nervous system. In: DeVita VT Jr, Hellman S, Rosenberg SA, eds. Cancer: principles and practice of oncology, 6th edn. Philadelphia: Lippincott Williams & Wilkins, 2001:2100-60.
29. K. Nemoto Y. Ogawa H. Matsushita 2002 Intraoperative radiation therapy (IORT) for previously untreated malignant gliomas BMC Cancer 2 1
30. C. Nieder U. Nestle M. Niewald 1999 Hyperfractionated reirradiation for malignant glioma Front Radiat Ther Oncol 33 150 7
31. S. Patel J.C. Breneman R.E. Warnik 2000 Permanent iodine 125 interstitial implants for the treatment of recurrent glioblastoma multiforme Neurosurgery 46 1123 8
32. M.D. Piroth B. Gagel M. Pinkawa 2007 Postoperative radiotherapy of glioblastoma multiforme. Analysis and critical assessment of different treatment strategies and predictive factors Strahlenther Onkol 183 695 702
33. D.A. Reardon G. Akabani R.E. Coleman 2006 Salvage radioimmunotherapy with murine iodine-131-labeled antitenascin monoclonal antibody 81C6 for patients with recurrent primary and metastatic malignant brain tumors: phase II study results [Erratum in: J Clin Oncol 2006;24:1484] J Clin Oncol 24 115 22
34. P. Schueller O. Micke S. Palkovic 2005 12 years' experience with intraoperative radiotherapy (IORT) of malignant gliomas Strahlenther Onkol 181 500 6
35. E. Shaw C. Scott L. Souhami 2000 Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05 Int J Radiat Oncol Biol Phys 47 291 8
36. J.M. Simon P. Cornu G. Boisserie 2002 Brachytherapy of glioblastoma recurring in previously irradiated territory: predictive value of tumor volume Int J Radiat Oncol Biol Phys 53 67 74
37. P.K. Sneed P.H. Gutin D.A. Larson 1994 Patterns of recurrence of glioblastoma multiforme after external irradiation followed by implant boost Int J Radiat Oncol Biol Phys 29 719 27
38. R. Stupp W.P. Mason M.J. van den Bent 2005 Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N Engl J Med 352 987 96
39. M.J. Taphoorn R. Stupp C. Coens 2005 Health-related quality of life in patients with glioblastoma: a randomised controlled trial Lancet Oncol 6 937 44
40. B. Timmermann A.J. Lomax L. Nobile 2007 Novel technique of craniospinal axis proton therapy with the spot-scanning system. Avoidance of patching multiple fields and optimized ventral dose distribution Strahlenther Onkol 183 685 8
41. N. Tselis C. Kolotas G. Birn 2007 CT-guided interstitial HDR brachytherapy for recurrent glioblastoma multiforme. Long-term results Strahlenther Onkol 183 563 70
42. S. Valtonen U. Timonen P. Toivanen 1997 Interstitial chemotherapy with carmustine-loaded polymers for high-grade gliomas: a randomized double-blind study Neurosurgery 41 44 8
43. G.M. Videtic L.E. Gaspar L. Zamorano 1999 Use of the RTOG recursive partitioning analysis to validate the benefit of iodine-125 implants in the primary treatment of malignant gliomas Int J Radiat Oncol Biol Phys 45 687 92
44. K.E. Wallner J.H. Galicich G. Krol 1989 Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma Int J Radiat Oncol Biol Phys 16 1405 9